Literature DB >> 8043585

Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.

M Ploug1, V Ellis, K Danø.   

Abstract

The cellular receptor for urokinase-type plasminogen activator (uPAR) is a glycolipid-anchored membrane protein thought to play a primary role in the generation of pericellular proteolytic activity, and to be involved in cancer cell invasion and metastasis. This protein is composed of three homologous domains, the NH2-terminal of which is involved in the high-affinity binding (Kd approximately 0.1-1.0 nM) to the epidermal growth factor-like module of urokinase-type plasminogen activator (uPA). Here we report that intact uPAR binds the low molecular weight fluorophore 8-anilino-1-naphthalenesulfonate (ANS) to form a 1:1 stoichiometric complex and that the resulting enhancement of the ANS fluorescence probes the functional state of uPAR as judged by several independent criteria. First, the uPAR-mediated increase in ANS fluorescence can be titrated by uPA as well as by its receptor binding derivatives (the amino-terminal fragment and the growth factor-like module). Second, an anti-uPAR monoclonal antibody, capable of preventing uPA binding, can also titrate the uPAR-dependent ANS fluorescence whereas other antibodies not interfering with uPA binding are unable to exert this effect. Third, the dissociation profile of uPA-uPAR complexes as a function of increasing concentrations of guanidine hydrochloride closely parallels the loss of the ANS binding site in uPAR. Finally, liberation of the NH2-terminal domain from uPAR by limited chymotrypsin cleavage after Tyr87 leads to a loss of both enhanced ANS fluorescence and high-affinity uPA binding.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043585     DOI: 10.1021/bi00196a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Isolation and characterization of cell lines with reduced urokinase binding.

Authors:  H K Lau; J M Teitel; M Kim
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

3.  Interactions of 8-anilino-1-naphthalenesulfonic acid (ANS) and cytochrome P450 2B1: role of ANS as an effector as well as a reporter group.

Authors:  X C Yu; H W Strobel
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

4.  Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.

Authors:  R W Colman; R A Pixley; S Najamunnisa; W Yan; J Wang; A Mazar; K R McCrae
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Hydroperoxide-mediated cytochrome P450-dependent 8-anilino-1-naphthalenesulfonic acid destruction, product formation and P450 modification.

Authors:  X C Yu; H W Strobel
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

6.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

Authors:  M Resnati; I Pallavicini; J M Wang; J Oppenheim; C N Serhan; M Romano; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

7.  A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

Authors:  F Fazioli; M Resnati; N Sidenius; Y Higashimoto; E Appella; F Blasi
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

8.  Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.

Authors:  Lily Yang; Hui Mao; Zehong Cao; Y Andrew Wang; Xianghong Peng; Xiaoxia Wang; Hari K Sajja; Liya Wang; Hongwei Duan; Chunchun Ni; Charles A Staley; William C Wood; Xiaohu Gao; Shuming Nie
Journal:  Gastroenterology       Date:  2009-01-14       Impact factor: 22.682

9.  Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Authors:  Orla Cunningham; Annapaola Andolfo; Maria Lisa Santovito; Lucia Iuzzolino; Francesco Blasi; Nicolai Sidenius
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

10.  Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.

Authors:  Line V Hansen; Henrik Gårdsvoll; Boye S Nielsen; Leif R Lund; Keld Danø; Ole N Jensen; Michael Ploug
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.